血小板活化及内皮细胞在原位肺动脉血栓形成中作用机制的研究进展
Research Progress in the Mechanism of Platelet Activation and Endothelial Cells in In Situ Pulmonary Artery Thrombosis
DOI: 10.12677/ACM.2021.1112850, PDF,    科研立项经费支持
作者: 许小艳：重庆医科大学，重庆；李桂琼*：重庆医科大学附属第二医院，重庆
关键词: 肺栓塞；原位肺动脉血栓形成；内皮细胞；血小板活化；Pulmonary Embolism； In Situ Pulmonary Artery Thrombosis； Endothelial Cell； Platelet Activation
摘要: 普遍认为，肺栓塞是由静脉血栓脱落，随血流进入肺动脉造成梗死。这一概念在临床实践中持续了一个多世纪。但随着越来越多的检查技术的出现，发现了在许多情况下，越来越多的肺栓塞找不到明显的栓子来源。包括慢性阻塞性肺疾病、哮喘、急诊/择期手术、病毒性肺炎等，上述疾病都有发现肺栓塞的形成，却未发现深静脉血栓。对于原位肺动脉血栓形成的过程，经过实验及临床观察证明，内皮细胞及血小板活化起了关键性作用。内皮功能障碍、缺氧、炎症细胞因子、基因突变等均是原位肺动脉血栓形成的基础。这篇综述将会讨论原位肺动脉血栓形成的潜在机制。
Abstract: It is generally believed that the pulmonary embolism is from venous thrombosis, and the blood flow is formed into pulmonary artery. This concept lasted for more than a century in clinical practice. However, with more and more inspection techniques, the embolus is not found in many pulmonary embolism cases, including chronic obstructive pulmonary disease, asthma, emergency/alternative surgery, viral pneumonia, etc. The above diseases have foundation of pulmonary embolism without deep vein thrombosis. After experimentation and clinical observation, endothelial cells and platelet activation plays a key role in the formation of in situ pulmonary artery thrombosis. Endothelial dysfunction, hypoxia, inflammatory cytokine, gene mutation, etc. are the foundations of in situ pulmonary artery thrombosis. This review will discuss the potential mechanism of the in situ pulmonary artery thrombosis.
文章引用：许小艳, 李桂琼. 血小板活化及内皮细胞在原位肺动脉血栓形成中作用机制的研究进展[J]. 临床医学进展, 2021, 11(12): 5747-5753. https://doi.org/10.12677/ACM.2021.1112850

参考文献

[1] Bertoletti, L., Quenet, S., Laporte, S., Sahuquillo, J.C., Conget, F., Pedrajas, J.M., Martin, M., Casado, I., Riera-Mestre, A., Monreal, M. and RIETE Investigators. (2013) Pulmonary Embolism and 3-Month Outcomes in 4036 Patients with venous Thromboembolism and Chronic Obstructive Pulmonary Disease: Data from the RIETE Registry. Respiratory Research, 14, 75.
[2] Ribeiro, D.D., Lijfering, W. M., Van Hylckama Vlieg, A., et al. (2012) Pneumonia and Risk of Venous Thrombosis: Results from the MEGA Study. Journal of Thrombosis and Haemostasis, 10, 1179-1182. [Google Scholar] [CrossRef] [PubMed]
[3] Børvik, T., Evensen, L.H., Morelli, V.M., Melbye, H., Brækkan, S.K. and Hansen, J.B. (2020) Impact of Respiratory Symptoms and Oxygen Saturation on the Risk of Incident venous Thromboembolism—The Tromsø Study. Research and Practice in Thrombosis and Haemostasis, 4, 255-262. [Google Scholar] [CrossRef] [PubMed]
[4] Ackermann, M., Verleden, S.E., Kuehnel, M., Haverich, A., Welte, T., Laenger, F., et al. (2020) Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. New England Journal of Medicine, 383, 120-128. [Google Scholar] [CrossRef] 
[5] Akpinar, E.E., Hoşgün, D., Akpinar, S., Ataç, G.K., Doğanay, B. and Gülhan, M. (2014) Incidence of Pulmonary Embolism during COPD Exacerbation. Jornal Brasileiro de Pneumologia, 40, 38-45. [Google Scholar] [CrossRef] 
[6] Dessap, A.M., Deux, J.F., Abidi, N., Lavenu-Bombled, C., Melica, G., Renaud, B., et al. (2011) Pulmonary Artery Thrombosis during Acute Chest Syndrome in Sickle Cell Disease. American Journal of Respiratory and Critical Care Medicine, 184, 1022-1029. [Google Scholar] [CrossRef] 
[7] 王汉, 李儒琳. 血清血小板活化因子、脂蛋白(a)、纤维蛋白单体对骨折患者发生近端深静脉血栓评估价值[J]. 创伤与急危重病医学, 2021, 9(2): 120-123.
[8] Simes, J., Becattini, C., Agnelli, G., Eikelboom, J.W., Kirby, A.C., Mister, R., Prandoni, P., Brighton, T.A. and for the INSPIRE Study Investigators (International Collaboration of Aspirin Trials for Recurrent Venous Thromboembolism). (2014) Aspirin for the Prevention of Recurrent venous Thromboembolism: The INSPIRE Collaboration. Circulation, 130, 1062-1071.[CrossRef] 
[9] Hsia, C.W., Tsai, C.L., Sheu, J.R., Lu, W.J., Hsia, C.H., Velusamy, M., Jayakumar, T. and Li, J.Y. (2019) Suppression of Human Platelet Activation via Integrin αIIbβ3 Outside-In Independent Signal and Reduction of the Mortality in Pulmonary Thrombosis by Auraptene. International Journal of Molecular Sciences, 20, Article No. 5585. [Google Scholar] [CrossRef] [PubMed]
[10] Lova, P., Canobbio, I., Guidetti, G.F., Balduini, C. and Torti, M. (2010) Thrombin Induces Platelet Activation in the Absence of Functional Protease Activated Receptors 1 and 4 and Glycoprotein Ib-IX-V. Cellular Signalling, 22, 1681-1687. [Google Scholar] [CrossRef] [PubMed]
[11] Frantzeskaki, F., Armaganidis, A. and Orfanos, S.E. (2017) Immunothrombosis in Acute Respiratory Distress Syndrome: Cross Talks between Inflammation and Coagulation. Respiration, 93, 212-225. [Google Scholar] [CrossRef] [PubMed]
[12] Mangalmurti, N.S., Friedman, J.L., Wang, L.C., Stolz, D., Muthukumaran, G., Siegel, D.L., Schmidt, A.M., Lee, J.S. and Albelda, S.M. (2013) The Receptor for Advanced Glycation End Products Mediates Lung Endothelial Activation by RBCs. American Journal of Physiology—Lung Cellular and Molecular Physiology, 304, L250-L263. [Google Scholar] [CrossRef] [PubMed]
[13] Maugeri, N., Campana, L., Gavina, M., Covino, C., De Metrio, M., Panciroli, C., Maiuri, L., Maseri, A., D’Angelo, A., Bianchi, M.E., Rovere-Querini, P. and Manfredi, A.A. (2014) Activated Platelets Present High Mobility Group Box 1 to Neutrophils, Inducing Autophagy and Promoting the Extrusion of Neutrophil Extracellular Traps. Journal of Thrombosis and Haemostasis, 12, 2074-2088. [Google Scholar] [CrossRef] [PubMed]
[14] 冀磊, 李占强, 芦殿香. HIF-2α在肺动脉高压中的研究进展[J/OL]. 药学学报, 2021: 1-22. 2021-11-13.[CrossRef] 
[15] Tyagi, T., Ahmad, S., Gupta, N., Sahu, A., Ahmad, Y., Nair, V., Chatterjee, T., Bajaj, N., Sengupta, S., Ganju, L., Singh, S.B. and Ashraf, M.Z. (2014) Altered Expression of Platelet Proteins and Calpain Activity Mediate Hypoxia-Induced Prothrombotic Phenotype. Blood, 123, 1250-1260. [Google Scholar] [CrossRef] [PubMed]
[16] Boilard, E., Paré, G., Rousseau, M., Cloutier, N., Dubuc, I., Lévesque, T., Borgeat, P. and Flamand, L. (2014) Influenza virus H1N1 Activates Platelets through FcγRIIA Signaling and Thrombin Generation. Blood, 123, 2854-2863. [Google Scholar] [CrossRef] [PubMed]
[17] Ashar, H.K., Mueller, N.C., Rudd, J.M., Snider, T.A., Achanta, M., Prasanthi, M., Pulavendran, S., Thomas, P.G., Ramachandran, A., Malayer, J.R., Ritchey, J.W., Rajasekhar, R., Chow, V.T.K., Esmon, C.T. and Teluguakula, N. (2018) The Role of Extracellular Histones in Influenza Virus Pathogenesis. American Journal of Pathology, 188, 135-148. [Google Scholar] [CrossRef] [PubMed]
[18] 李世军, 张丽, 李小鹰. 阿司匹林与静脉血栓栓塞症的预防[J]. 中华老年心脑血管病杂志, 2017, 19(8): 878-880.
[19] Anderson, D.R., Dunbar, M.J., Bohm, E.R., Belzile, E., Kahn, S.R., Zukor, D., et al. (2013) Aspirin versus Low-Molecular-Weight Heparin for Extended venous Thromboembolism Prophylaxis after Total Hip Arthroplasty: A Randomized Trial. Annals of Internal Medicine, 158, 800-806. [Google Scholar] [CrossRef] [PubMed]
[20] Kearon, C., Akl, E.A., Ornelas, J., Blaivas, A., Jimenez, D., Bounameaux, H., et al. (2016) Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. Chest, 149, 315-352. [Google Scholar] [CrossRef] [PubMed]
[21] Mekaj, Y.H., Daci, F.T. and Mekaj, A.Y. (2015) New Insights into the Mechanisms of Action of Aspirin and Its Use in the Prevention and Treatment of Arterial and Venous Thromboembolism. Therapeutics and Clinical Risk Management, 11, 1449-1456. [Google Scholar] [CrossRef] 
[22] 马菁苑, 蔡雨春, 姚冬. 肺动脉高压中的肺血管重塑[J]. 医学研究生学报, 2021, 34(9): 985-990.
[23] Millar, F.R., Summers, C., Griffiths, M.J., Toshner, M.R. and Proudfoot, A.G. (2016) The Pulmonary Endothelium in Acute Respiratory Distress Syndrome: Insights and Therapeutic Opportunities. Thorax, 71, 462-473. [Google Scholar] [CrossRef] [PubMed]
[24] Marudamuthu, A.S., Bhandary, Y.P., Fan, L., Radhakrishnan, V., MacKenzie, B., Maier, E., Shetty, S.K., Nagaraja, M.R., Gopu, V., Tiwari, N., Zhang, Y., Watts, A.B., Williams 3rd., R.O., Criner, G.J., Bolla, S., Marchetti, N., Idell, S. and Shetty, S. (2019) Caveolin-1-Derived Peptide Limits Development of Pulmonary Fibrosis. Science Translational Medicine, 11, Article No. eaat2848. [Google Scholar] [CrossRef] [PubMed]
[25] Oliveira, S.D.S. and Minshall, R.D. (2018) Caveolin and Endothelial NO Signaling. Current Topics in Membranes, 82, 257-279. [Google Scholar] [CrossRef] [PubMed]
[26] Alberelli, M.A. and De Candia, E. (2014) Functional role of Protease Activated Receptors in Vascular Biology. Vascular Pharmacology, 62, 72-81. [Google Scholar] [CrossRef] [PubMed]
[27] 叶明棠, 丁培成, 莫绪明. 血管内皮糖萼降解与体外循环关系的研究进展[J]. 中国体外循环杂志, 2021, 19(4): 239-242+216.
[28] Chaurasia, S.N., Kushwaha, G., Kulkarni, P.P., Mallick, R.L., Latheef, N.A., Mishra, J.K. and Dash, D. (2019) Platelet HIF-2α Promotes Thrombogenicity through PAI-1 Synthesis and Extracellular Vesicle Release. Haematologica, 104, 2482-2492. [Google Scholar] [CrossRef] [PubMed]
[29] Gupta, N., Zhao, Y.Y. and Evans, C.E. (2019) The Stimulation of Thrombosis by Hypoxia. Thrombosis Research, 181, 77-83. [Google Scholar] [CrossRef] [PubMed]
[30] Green, C.E. and Turner, A.M. (2017) The Role of the Endothelium in Asthma and Chronic Obstructive Pulmonary disease (COPD). Respiratory Research, 18, Article No. 20. [Google Scholar] [CrossRef] [PubMed]
[31] Lee, S.H., Lee, S.H., Kim, C.H., Yang, K.S., Lee, E.J., Min, K.H., Hur, G.Y., Lee, S.H., Lee, S.Y., Kim, J.H., Shin, C., Shim, J.J., In, K.H., Kang, K.H. and Lee, S.Y. (2014) Increased Expression of Vascular Endothelial growth Factor and Hypoxia Inducible Factor-1α in Lung Tissue of Patients with Chronic Bronchitis. Clinical Biochemistry, 47, 552-559. [Google Scholar] [CrossRef] [PubMed]
[32] 吕炜, 王乐民, 龚朱, 王嫱, 郜恒骏, 沈晓莹. 肺栓塞患者外周血单个核细胞干扰素相关基因mRNA表达[J]. 中华内科杂志, 2012, 51(4): 270-273.
[33] Li, M.Y., Li, L., Zhang, Y. and Wang, X.S. (2020) Expression of the SARS-CoV-2 Cell Receptor Gene ACE2 in a Wide Variety of Human Tissues. Infectious Diseases of Poverty, 9, Article No. 45. [Google Scholar] [CrossRef] [PubMed]

为你推荐